AF screening for people with heart changes on echo
Part of Heart & circulation clinical trials.
This trial checks if people with certain heart conditions seen on an echo (like an enlarged heart or stiff heart muscle) have undetected atrial fibrillation (AF). It aims to find AF early so it can be treated to prevent strokes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have at least one of these heart conditions on an echo: enlarged left atrium (LAE), thickened heart muscle (LVH), or a stiff heart muscle (E/e' > 14).
- You have moderate or severe diastolic dysfunction (grade II or III).
- You have heart valve disease (VHD).
- You have heart failure with a weak pumping heart (LVEF < 40%) or heart failure with preserved pumping heart (LVEF ≥ 40%) plus symptoms and a high NT-proBNP level.
- You have never been diagnosed with atrial fibrillation or atrial flutter.
- You do not have congenital heart disease, recent heart attack (within 3 months), uncontrolled overactive thyroid, end-stage kidney disease, unstable blood pressure, or a life expectancy less than 1 year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using an artificial intelligence (AI) system to read your electrocardiogram (ECG, a heart rhythm test) can better evaluate your heart's structure and function, helping manage atrial fibrillation (AF). You may qualify if you have AF and need an echocardiogram (ultrasound of the heart).
This study uses advanced heart scans and AI technology to find early signs of amyloidosis (a protein buildup in the heart) in people with atrial fibrillation. Catching it early may help prevent serious heart problems.
This trial uses a special long-term heart monitor (one wire) that uses artificial intelligence to find new cases of atrial fibrillation, a type of irregular heartbeat that can increase stroke risk. If you're 60 or older and haven't had AF before, this study could help catch it early.
This trial uses an AI tool to analyze your heart's electrical signals (ECG) to better understand your risk of heart failure and how well your heart recovers after a procedure called catheter ablation for atrial fibrillation. It may help guide your treatment if you have early signs of heart failure.
This study tests a new way to use ultrasound (echocardiogram) to measure heart pressure in people who have both heart failure and atrial fibrillation (irregular heartbeat). Participants will have an ultrasound and a heart catheterization to see if the new ultrasound method can accurately detect elevated pressures.
This study tests using a new electrical pulse treatment for atrial fibrillation (AF) early on, in people who also have a type of heart failure where the heart pumps normally but is stiff. The goal is to see if this treatment helps manage both conditions better.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.